Select Page

Merck Acquires Neurodegenerative Biotech Calporta

Merck has acquired Calporta Therapeutics, Inc., a San Diego biotech focused on developing drugs that support lysosome function, which could combat diseases (including Alzheimer’s and Parkinson’s disease) linked to the toxic buildup of certain protein molecules. The...

Pin It on Pinterest